RNS (Repetitive Nerve Stimulation) Differential
I'm treating "RNS" here as Repetitive Nerve Stimulation, the electrodiagnostic test used to work up suspected neuromuscular junction (NMJ) disorders (if you meant something else - renal scan differential function, reactive nitrogen species, etc. - let me know and I'll pivot).
How the test works
A motor/mixed nerve is stimulated repetitively while recording the compound muscle action potential (CMAP):
- Slow RNS (2-3 Hz, 3-5 stimuli): depletes the immediately available acetylcholine (ACh) quanta faster than the mobilization store can replenish it.
- Rapid RNS (20-50 Hz, or CMAP after 10 seconds of brief exercise): causes calcium accumulation in the nerve terminal, transiently boosting ACh release.
Differential by pattern (Table 36.3, Bradley & Daroff's Neurology in Clinical Practice)
| NMJ Defect | Prototype Disorder | Baseline CMAP | Slow RNS | Rapid RNS |
|---|
| Postsynaptic | Myasthenia gravis | Normal | Decrement | Normal or decrement |
| Presynaptic | Lambert-Eaton myasthenic syndrome (LEMS) | Low | Decrement | Increment (often >100%, classically ≥200-300%) |
| Presynaptic | Botulism | Low (may be normal early) | Decrement | Increment (usually less dramatic than LEMS) |
| Postsynaptic (congenital) | Congenital myasthenic syndromes | Variable | Decrement | Variable |
Key discriminating logic
- Decrement on slow RNS alone -> suggests myasthenia gravis (postsynaptic AChR loss reduces the safety factor; baseline CMAP is normal because enough end-plates still reach threshold at rest).
- Low baseline CMAP + decrement on slow RNS + large increment on rapid RNS/post-exercise -> suggests a presynaptic disorder: Lambert-Eaton myasthenic syndrome (paraneoplastic, associated with small-cell lung cancer and P/Q-type voltage-gated calcium channel antibodies) or botulism (toxin-mediated blockade of ACh vesicle release).
- Clinically this pairs with exam findings: LEMS and botulism show post-exercise facilitation (transient strength improvement with brief contraction), whereas MG classically shows fatigable weakness that worsens with sustained effort.
Broader differential of conditions that prompt an RNS work-up: myasthenia gravis, Lambert-Eaton myasthenic syndrome, botulism, congenital myasthenic syndromes, and drug-induced myasthenic states (e.g., penicillamine, aminoglycosides, procainamide) - Tintinalli's Emergency Medicine, p. 574 (differential diagnosis of infant/adult NMJ weakness).
Supporting diagnostic context
Per Bradley and Daroff's Neurology in Clinical Practice (Diagnostic Procedures in Myasthenia Gravis), an abnormal RNS or increased jitter on single-fiber EMG - in the absence of nerve/muscle disease that could independently cause a decrement - supports the MG diagnosis, alongside elevated AChR/MuSK antibodies and a positive response to cholinesterase inhibitors.
- Bradley and Daroff's Neurology in Clinical Practice, p. 627 (Table 36.3, Figs. 36.18-36.19)
- Tintinalli's Emergency Medicine, p. 574
- Adams and Victor's Principles of Neurology, 12th Edition (Repetitive Motor Nerve Stimulation, Changes in the Contractile Process)
Recent evidence check: A quick PubMed screen for recent systematic reviews/meta-analyses on RNS diagnostic accuracy in MG/LEMS wasn't run in this session due to the interpretation being confirmed from textbook content only - if you want, I can pull current literature (e.g., comparative sensitivity of RNS vs. single-fiber EMG vs. antibody testing) next.